Elevance HealthMEX:ELV 71 Shareholder Yield % is 2.00% as of Mar. 2026, which is 2% above its 10-year median of 1.97. GuruFocus rates MEX:ELV with a GF Score™ of 71/100 and a GF Value™ of MXN8,687.10 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 17 Healthcare Plans companies, Elevance Health ranks worse than 58.82% on this metric.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return.
As of today, Elevance Health's Shareholder Yield % was 2.00%.
Elevance Health (MEX:ELV) Shareholder Yield % Explanation
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."
Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.
Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.
Elevance Health Shareholder Yield % Related Terms
Elevance Health Shareholder Yield % Historical Data
* Premium members only.
The historical data trend for Elevance Health's Shareholder Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:ELV vs CI, HUM, CVS: Shareholder Yield % Comparison
For the Healthcare Plans subindustry, Elevance Health's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elevance Health Shareholder Yield % vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Elevance Health's Shareholder Yield % distribution charts can be found below:
* The bar in red indicates where Elevance Health's Shareholder Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
Elevance Health (MEX:ELV) has a Shareholder Yield % of 2.00% as of Mar. 2026. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Elevance Health and its competitors. This is near median its historical median of 1.97. According to the industry distribution chart, Elevance Health ranks #10 out of 17 companies in the Healthcare Plans industry, placing it in the top 58.8%.
Is Elevance Health's Shareholder Yield % too high?
Elevance Health's current Shareholder Yield % of 2.00% is near median its 10-year median of 1.97. The Healthcare Plans industry median Shareholder Yield % is 2.30. Elevance Health's value of 2.00% is 13% below this industry median. Based on the distribution chart, Elevance Health ranks #10 out of 17 companies in the Healthcare Plans industry, which is below the industry midpoint. Overall, Elevance Health has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elevance Health's Shareholder Yield % compare to CI and HUM?
According to the Healthcare Plans industry distribution chart, Elevance Health ranks #10 out of 17 companies for Shareholder Yield %. This places Elevance Health in the lower half of its industry. The industry median Shareholder Yield % is 2.30. Elevance Health's value of 2.00% is 13% below this benchmark. While the company's 10-year median is 1.97 vs. the industry median of 2.30, Elevance Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Healthcare Plans company?
The median Shareholder Yield % among Healthcare Plans companies is 2.30, based on 17 companies in the industry. Companies in the top quartile (top 25%) have a Shareholder Yield % significantly above this median, while those in the bottom quartile fall well below. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Elevance Health's current Shareholder Yield % of 2.00% is 13% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Elevance Health and its competitors. For the Healthcare Plans industry, the median Shareholder Yield % is 2.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elevance Health's current Shareholder Yield % is 2.00%, which is near median its own 10-year median of 1.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elevance Health stock overvalued right now?
Based on GuruFocus' analysis, Elevance Health (MEX:ELV) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN8,687.10, compared to a current price of MXN7,144.06 — trading 17.8% below its estimated fair value. The current Shareholder Yield % is 2.00%, which is near median its 10-year median of 1.97 and 13% below the Healthcare Plans industry median of 2.30. Elevance Health's overall GF Score™ is 71/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For Elevance Health (MEX:ELV), the current Shareholder Yield % is 2.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Elevance Health (MEX:ELV) Overvalued in 2026?
Based on GuruFocus' analysis, Elevance Health stock appears to be undervalued.
The current stock price of MXN7,144.06 is trading 17.8% below its estimated GF Value™ of MXN8,687.10.
GuruFocus considers Elevance Health to be Modestly Undervalued.
Key valuation signals for MEX:ELV:
Shareholder Yield %: 2.00% (near median its 10-year median of 1.97)
GF Value™: MXN8,687.10 vs. price of MXN7,144.06 (17.8% below fair value)
Industry Position: 13% below the Healthcare Plans median (#10 of 17)
No single metric tells the full story. See the MEX:ELV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
71GF Score
Get the complete analysis for MEX:ELV
Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:ELV has been successfully added to your 
